Pricing New Drugs for COVID-19 in the Pharmaceutical Industry: Insights From the Chinese Medical Insurance
Int J Health Policy Manag
.
2023:12:7972.
doi: 10.34172/ijhpm.2023.7972.
Epub 2023 Jun 18.
Authors
Jinmiao Lu
1
,
Xiaohua Ying
2
,
Zhiping Li
1
Affiliations
1
Department of Clinical Pharmacy, National Children's Medical Center, Children's Hospital of Fudan University, Shanghai, China.
2
NHC Key Laboratory of Health Technology Assessment, Department of Health Economics, School of Public Health, Fudan University, Shanghai, China.
PMID:
37579370
PMCID:
PMC10461880
DOI:
10.34172/ijhpm.2023.7972
No abstract available
Publication types
Letter
MeSH terms
COVID-19*
China
Costs and Cost Analysis
Drug Costs
Drug Industry
Insurance*
Insurance, Pharmaceutical Services